IDEAYA Biosciences, Inc. (IDYA) stock
IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/309% above fair value
$31.83+0.34 (+1.08%)
Close on Nov 13, 2026Market cap $3.07BP/E –Yield –
IDEAYA Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
IDEAYA Biosciences's enterprise value was $2.32B on Nov 11, 2026, against $2.34B a year earlier. Over the last 5 years it ranged from $111.84M to $3.04B, with a median of $1.38B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.32B | +3.6% |
| 2025 | Dec 31, 2025 | $2.24B | +72.7% |
| 2024 | Dec 31, 2024 | $1.30B | -19.7% |
| 2023 | Dec 29, 2023 | $1.62B | +231.7% |
| 2022 | Dec 30, 2022 | $487.56M | -24.4% |
| 2021 | Dec 31, 2021 | $644.72M | +402.7% |
| 2020 | Dec 31, 2020 | $128.24M | +197.8% |
| 2019 | Dec 31, 2019 | $43.06M | – |
See a number that looks wrong?